R-HP210
R-HP210 acts on the NF-κB mediated tethered transrepression function (IC50=3.80 μM) . R-HP210 represses the LPS-induced transcription of a variety of proinflammatory genes such as IL-1β, IL-6 and COX-2. R-HP210 does not induce the transactivation functions of Glucocorticoids (GCs) [1].
Product Specifications
UNSPSC
12352005
Target
NF-κB
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/r-hp210.html
Purity
98.21
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
C[C@H](C1=CC=CC=C1)NC(C2=CC=C(C=C2)CN3C(C4=C(NC3=S)C=CS4)=O)=O
Molecular Formula
C22H19N3O2S2
Molecular Weight
421.54
References & Citations
[1]Xueping Hu, et al. Discovery of novel non-steroidal selective glucocorticoid receptor modulators by structure- and IGN-based virtual screening, structural optimization, and biological evaluation. Eur J Med Chem. 2022 Jul 5;237:114382.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NF-κB
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Ethyl 7-Aminothieno[2,3-b]pyrazine-6-carboxylate](https://cdn.genprice.uk/products/572/8263041517339/imageurl/trc-e899665-500mg.webp)
TRC-E899665-500MG 500 mg
Ethyl 7-Aminothieno[2,3-b]pyrazine-6-carboxylate
Sign In for Pricing
View Details 
